Popular Articles
Benefits Of Grapefruit

Study Sees Transient Heart Dysfunction In Some Long-Distance Runners
A new study using advanced cardiac imaging technology indicates that cardiac abnormalities experienced by some marathon runners following competition are temporary, and do not result in damage to the heart muscle. The study, conducted by researchers at the University of Manitoba, marked the first use of cardiac magnetic resonance imaging, or CMR, in a post-marathon setting.
generic viagra online
U Of M Study Finds New Insight On Therapy For A Devastating Parasitic Disease
University of Minnesota Medical School researchers have discovered an important new insight into how a commonly prescribed drug may work to treat those infected by a parasitic flatworm.
News of the day
Democratic Female Senators Praise Supreme Court Nominee Sotomayor
Several Democratic female senators on Wednesday took to the floor in a series of speeches praising Supreme Court nominee Sonia Sotomayor and highlighting her judicial qualifications, the Boston Globe"s "Political Intelligence" reports. Sen. Amy Klobuchar (Minn.) -- a member of the Senate Judiciary Committee -- was joined by Sens. Mary Landrieu (La.), Claire McCaskill (Mo.) and Jeanne Shaheen (N.H.).In her address, Klobuchar said that Sotomayor"s experience "particularly resonated with me," adding that Sotomayor "understands the law is not just some dusty book in your basement" and that its interpretation has consequences. McCaskill said that Sotomayor is a nominee with "integrity, grit, intellect and the ability to pass judgment in the most difficult intellectual challenges that face a Supreme Court justice."According to "Political Intelligence," the floor speeches came after Klobuchar and others praised Sotomayor"s nomination at Monday"s annual convention of the left-leaning legal organization the American Constitution Society. In her speech, Klobuchar defended Sotomayor against conservative critics who have questioned the nominee"s temperament, citing complaints that Sotomayor was impatient with unprepared lawyers. Klobuchar said that she is "hoping that we would get to a point in this country where we could be appointing and confirming as many as rough and to-the-point female judges as we have appointed male judges" ("Political Intelligence," Boston Globe, 6/24).
Medical Devices

Advanced Prostate Cancer - New Review On PROSTVAC(TM) Published By Key Investigators From NCI

A just published Review in the publication "Expert Opinion on Investigational Drugs", Volume 18, Issue 7 2009, confirms the previous published information on PROSTVAC(TM). This is the most comprehensive and updated Review on PROSTVAC(TM) so far. Quote from the article: "Preliminary clinical trials have indicated negligible toxicity, and Phase II trials have suggested a survival benefit after treatment with PROSTVAC(TM), especially in patients with indolent disease characteristics." Anders Hedegaard, President & CEO of Bavarian Nordic said: "We are very pleased that the scientific experts once again confirm their positive view on PROSTVAC(TM) and the potential use of the vaccine in earlier stages of the disease. We are looking forward to publish more data at a later stage." Background information: PROSTVAC(TM) is a therapeutic vaccine moving into late stage clinical development that has the potential to extend the lives of people with advanced prostate cancer. Administered subcutaneously, it induces a specific, targeted immune response that attacks prostate cancer cells. Conventional chemotherapy currently used to treat prostate cancer has limited survival rates and is often associated with numerous side effects. In contrast, PROSTVAC(TM) has the potential to extend survival with improved quality of life. PROSTVAC is being developed in collaboration with the National Cancer Institute under a Cooperative Research and Development Agreement with Bavarian Nordic"s U.S.-based subsidiary, BN ImmunoTherapeutics. In clinical trials to date PROSTVAC(TM) and related PSA containing poxviral vaccines have been investigated in more than 500 patients for 10 years. Bavarian Nordic


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):